Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05482737 · ClinicalTrials.gov registry record
Clinical Impact of Red Cell Storage Age
A clinical trial of RBC Transfusions, sponsored by University of Minnesota.
- Completed
- Registry status
- 33,000
- Enrollment target
- 1
- Study location
NCT05482737: Completed study of RBC Transfusions, sponsored by University of Minnesota.
NCT05482737 is a study of RBC Transfusions that has completed, run by University of Minnesota. The registered enrollment target is 33,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05482737, a study of RBC Transfusions, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 33,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The recent four RCTs evaluating effects of RBC storage age on morbidity and mortality found no statistically significant adverse effects of longer stored RBC compared to shorter storage ages. Unfortunately, none of these RCTs had sufficient numbers of subjects receiving RBC at either storage age extreme to identify consequences of RBC transfusion at these limits. To better investigate effects of RBC storage age on clinical outcomes, this study will perform secondary meta-analyses of merged common patient data elements -individual patient data (IPD) meta-analysis (IPDMA) - from the nearly 33,000 subjects enrolled in the four RCTs.
Primary Outcome
Estimate the effect of transfused RBC storage-age on time to all-cause mortality
Conditions Studied
Interventions
- OTHER no intervention
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33,000 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2024-08-30 |
What the finished NCT05482737 record still lists
NCT05482737 is an observational study that tracks outcomes without assigning an intervention. Its 33,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with RBC Transfusions appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.
NCT05482737 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05482737 about?
NCT05482737 is a clinical study titled "Clinical Impact of Red Cell Storage Age". The recent four RCTs evaluating effects of RBC storage age on morbidity and mortality found no statistically significant adverse effects of longer stored RBC compared to shorter storage ages. Unfortunately, none of these RCTs had sufficient numbers of subjects receiving RBC at either storage age ext...
What is the current status of trial NCT05482737?
This trial is currently completed. The enrollment target is 33,000 participants. The study started on 2019-07-01. Estimated completion is 2024-08-30.
What conditions does trial NCT05482737 study?
This clinical trial studies the following conditions: RBC Transfusions.
What interventions are being tested in trial NCT05482737?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT05482737?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05482737 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI